The uptake of surgery was related to risk of developing ovarian cancer as demonstrated by a significantly higher uptake in BRCA1 mutation carriers, who have a lifetime ovarian cancer risk of 39–65%, compared with BRCA2 mutation carriers, whose lifetime risks are 10–37%. The gene discussed is BRCA1; the disease is ovarian carcinoma.